|
Delayed
Sao Paulo
20:21:25 18/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 86.64 BRL | -85.05% |
|
+1.69% | +10.74% |
| 08-12 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| 08-11 | Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating | MT |
| Market Cap | 131B 681B 113B 106B 96.51B 182B 12,520B 184B 1,246B 488B 6,262B 491B 480B 20,857B | P/E 2026 * |
30.4x | P/E 2027 * | 24.9x |
|---|---|---|---|---|---|
| Enterprise Value | 116B 607B 101B 94.61B 85.99B 162B 11,156B 164B 1,110B 435B 5,579B 437B 428B 18,584B | EV / Sales 2026 * |
8.83x | EV / Sales 2027 * | 7.7x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -85.05% | ||
| 1 week | +1.69% | ||
| Current month | +12.33% | ||
| 1 month | +12.34% | ||
| 3 months | +26.65% | ||
| 6 months | +12.24% | ||
| Current year | +10.74% |
| 1 week | 81.61 |  | 86.64 |
| 1 month | 74.56 | | 86.64 |
| Current year | 65.18 | | 86.64 |
| 1 year | 62.2 | | 86.64 |
| 3 years | 52.29 | | 93.56 |
| 5 years | 30.22 | | 93.56 |
| 10 years | 20.29 | | 93.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 01/04/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 10/04/2019 |
Sean Daughtry
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 01/01/1998 |
Jeffrey Leiden
CHM | Chairman | 70 | 01/05/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 18/06/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -85.05% | +1.69% | - | - | 131B | |
| +2.88% | +0.34% | +74.65% | +123.11% | 1,055B | |
| +3.33% | +4.38% | +53.85% | +57.21% | 632B | |
| +3.03% | +3.30% | +25.07% | +72.08% | 442B | |
| +1.35% | -2.17% | +40.98% | +41.50% | 351B | |
| +1.75% | -0.24% | +25.28% | +40.46% | 290B | |
| +2.13% | -0.32% | +0.58% | +10.77% | 243B | |
| +1.42% | +2.71% | +45.42% | +62.52% | 227B | |
| +1.35% | -3.53% | -14.72% | -52.63% | 200B | |
| +3.10% | +5.74% | +21.68% | +89.20% | 172B | |
| Average | -6.43% | -1.44% | +30.31% | +49.36% | 401.39B | |
| Weighted average by Cap. | -0.50% | -1.87% | +43.41% | +68.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.19B 68.78B 11.39B 10.72B 9.74B 18.32B 1,264B 18.59B 126B 49.27B 632B 49.52B 48.45B 2,105B | 14.58B 76.05B 12.6B 11.85B 10.77B 20.26B 1,397B 20.56B 139B 54.48B 699B 54.76B 53.57B 2,328B |
| Net income | 4.31B 22.45B 3.72B 3.5B 3.18B 5.98B 413B 6.07B 41.04B 16.08B 206B 16.16B 15.81B 687B | 5.22B 27.21B 4.51B 4.24B 3.85B 7.25B 500B 7.35B 49.74B 19.49B 250B 19.59B 19.16B 833B |
| Net Debt | -14.24B -74.26B -12.3B -11.57B -10.52B -19.78B -1,365B -20.07B -136B -53.2B -682B -53.47B -52.31B -2,273B | -18.44B -96.14B -15.92B -14.98B -13.62B -25.61B -1,767B -25.99B -176B -68.88B -884B -69.22B -67.72B -2,943B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/08/26 | R$86.64 | -85.05% | 57 |
| 14/08/26 | R$83.28 | -1.87% | 112 |
| 12/08/26 | R$84.87 | -0.39% | 4 |
| 11/08/26 | R$85.20 | +2.49% | 901 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
- VRTX34 Stock
Select your edition
All financial news and data tailored to specific country editions
